The Stop CMV Act of 2024 requires hospitals and health care facilities to offer newborn screening tests for congenital Cytomegalovirus, a serious viral infection that can cause hearing loss, developmental delays, and other health problems in infants. Each state would establish its own standards and procedures for administering these tests to infants 21 days old or younger, with the federal government providing oversight through an existing advisory committee. The bill authorizes federal grants to support state implementation of screening programs and directs the Centers for Disease Control and Prevention to help states collect data and educate health care providers and the public about the condition. Additionally, the National Institutes of Health would conduct research on improved screening techniques and develop treatments and vaccines for congenital Cytomegalovirus. The legislation authorizes unspecified funding for fiscal years 2024 and 2025 through the Health Resources and Services Administration and the CDC, while the NIH would use existing appropriations for its research activities.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.